OUR PARTNERS
Major Partner
Founded in 1977, Balt is a pioneering family company, always leading in Interventional Neuroradiology. Balt completely controls its R&D policy with the constant underlying objective of innovating, making it one of the world Id leaders in its field. Constantly growing, Balt remains the one and only European company facing multinationals.
SUPPORTER Partner
Making healthcare better is our priority and we believe technology can play an even greater role in improving people’s lives. In addition to alleviating pain, restoring health, extending lives, we work in partnership with others to create seamless, more efficient care.
contributor Partners
Acandis specialises in the development, manufacturing and marketing of innovative products for the treatment of neurovascular diseases.
Our products are used by interventional neuroradiologists for prevention and treatment of stroke – for the benefit of patients!
Johnson & Johnson MedTech Neurovascular is dedicated to advancing neurovascular care and changing the trajectory of stroke. Building on a long heritage of innovation, we work alongside physicians to help improve outcomes for patients. Our broad portfolio of neurovascular solutions supports the endovascular treatment of ischemic and hemorrhagic stroke.
Penumbra, Inc., headquartered in Alameda, California (USA) is a global healthcare company focused on interventional therapies that designs, develops, manufactures and markets innovative devices. The company has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular.
Rapid Medical expands what’s possible in neurovascular treatment by pioneering advanced interventional devices that treat ischemic and hemorrhagic stroke. Utilizing proprietary manufacturing techniques, Rapid Medical’s products are remotely adjustable and fully visible. This enables physicians to respond in real-time to the anatomy and tailor their approach to each patient for better procedural outcomes.
Stryker is one of the world’s leading medical technology companies and, together with our customers, is driven to make healthcare better. We offer innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Terumo Neuro provides a complete 360-degree approach to developing neuroendovascular technologies and currently consists of four main product groups: Aneurysm Therapy Solutions, Ischemic Stroke and Carotid Artery Disease Solutions, Neurovascular Malformation Solutions, and Access Products. Additionally, our extensive product lines in each category allow our customers to uniquely address and customize the needs of their patients for many types of situations. Looking toward the future, we are committed to excellence in everything we do, and we strive to continually improve and innovate. We are dedicated to achieving results that exceed expectations -our own and our customers’.
Wallaby Medical was founded with a focus on developing innovative, breakthrough, and clinically validated technologies and solutions for the treatment of neurovascular diseases. Wallaby Medical successfully acquired phenox GmbH, a leading global neurointerventional company based in Germany. As a result, we now offers a comprehensive and globally competitive portfolio of neurointerventional products, supported by multiple R&D centers and production bases, with a global team. the company’s vision is to "save more lives impacted by stroke."
For more information regarding sponsorship please contact:
Project Manager: Stacey Monsell
E-mail: NICO@overcome.eu
Phone: +33 (0)1 40 88 97 97